Similarly, in a murine model of inv(16) AML driven by rearrangement of CBFB (core-binding factor subunit beta), NRASG12D blocked cell death through upregulation of Bmi and the MEK pathway, the latter rendering this AML sensitive to MEK inhibitors (Xue et al., 2014). This evidence concerns the gene CBFB and acute myeloid leukemia.